Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy

Shahed N. Badiyan, Rajesh C. Rao, Anthony J. Apicelli, Sahaja Acharya, Vivek Verma, Adam A. Garsa, Todd Dewees, Christina K. Speirs, Jose Garcia-Ramirez, Jacqueline Esthappan, Perry W. Grigsby, J. William Harbour

Research output: Contribution to journalArticle

30 Scopus citations

Abstract

Purpose To assess the impact on local tumor control of intraoperative ultrasonographic plaque visualization and selective application of transpupillary thermotherapy (TTT) in the treatment of posterior uveal melanoma with iodine-125 (I-125) episcleral plaque brachytherapy (EPB). Methods and Materials Retrospective analysis of 526 patients treated with I-125 EPB for posterior uveal melanoma. Clinical features, dosimetric parameters, TTT treatments, and local tumor control outcomes were recorded. Statistical analysis was performed using Cox proportional hazards and Kaplan-Meier life table method. Results The study included 270 men (51%) and 256 women (49%), with a median age of 63 years (mean, 62 years; range, 16-91 years). Median dose to the tumor apex was 94.4 Gy (mean, 97.8; range, 43.9-183.9) and to the tumor base was 257.9 Gy (mean, 275.6; range, 124.2-729.8). Plaque tilt >1 mm away from the sclera at plaque removal was detected in 142 cases (27%). Supplemental TTT was performed in 72 patients (13.7%). One or 2 TTT sessions were required in 71 TTT cases (98.6%). After a median follow-up of 45.9 months (mean, 53.4 months; range, 6-175 months), local tumor recurrence was detected in 19 patients (3.6%). Local tumor recurrence was associated with lower dose to the tumor base (P=.02). Conclusions Ultrasound-guided plaque localization of I-125 EPB is associated with excellent local tumor control. Detection of plaque tilt by ultrasonography at plaque removal allows supplemental TTT to be used in patients at potentially higher risk for local recurrence while sparing the majority of patients who are at low risk. Most patients require only 1 or 2 TTT sessions.

Original languageEnglish (US)
Pages (from-to)801-805
Number of pages5
JournalInternational Journal of Radiation Oncology Biology Physics
Volume88
Issue number4
DOIs
StatePublished - Mar 15 2014

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy'. Together they form a unique fingerprint.

  • Cite this

    Badiyan, S. N., Rao, R. C., Apicelli, A. J., Acharya, S., Verma, V., Garsa, A. A., Dewees, T., Speirs, C. K., Garcia-Ramirez, J., Esthappan, J., Grigsby, P. W., & Harbour, J. W. (2014). Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy. International Journal of Radiation Oncology Biology Physics, 88(4), 801-805. https://doi.org/10.1016/j.ijrobp.2013.12.014